Dr. Du is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3009 N Ballas Rd
Ste 100B
Saint Louis, MO 63131Phone+1 314-432-1111Fax+1 314-432-7317- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemFellowship, Rheumatology, 2002 - 2004
- Mercy Hospital (St Louis)Residency, Internal Medicine, 1999 - 2002
- Washington University in St. LouisResearch Associate, Rheumatology, 1998 - 1999
- National Institutes of Health Clinical CenterRheumatology, 1991 - 1995
- West China University of Medical SciencesClass of 1986
Certifications & Licensure
- MO State Medical License 2004 - 2025
- IL State Medical License 2004 - 2005
- PA State Medical License 2002 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Five Star Excellence Award BJC Medical Group, 2013
- Clinical Fellow Award University of Pennsylvania, 2003
- Honors Fellow in Rheumatology Award Ortho-McNeil, 2003
- Join now to see all
Publications & Presentations
PubMed
- 26 citationsLocalization in rats of genetic loci regulating susceptibility to experimental erosive arthritis and related autoimmune diseasesRonald L. Wilder, Marie M. Griffiths, Elaine F. Remmers, Grant W. Cannon, Rachel R. Caspi
Transplantation Proceedings. 1999-05-01 - 2 citationsVoluntarily Postponing Testing Is Associated with Lower Performance on the Pediatric Board Certifying ExaminationsYing Du, Linda A. Althouse, Rachael Jin Bee Tan
The Journal of Pediatrics. 2016-10-01 - 175 citationsA genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats.Elaine F. Remmers, Ryan E. Longman, Ying Du, Ann M. O’Hare, Grant W. Cannon
Nature Genetics. 1996-09-01
Press Mentions
- Efficacy and Safety of PEGylated Exenatide Injection (PB-119) in Treatment-Naive Type 2 Diabetes Mellitus Patients: A Phase II Randomised, Double-Blind, Parallel, Placebo-Controlled StudyMarch 9th, 2021
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin), Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: